Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
XRP News Today: SEC Grants Approval for XRP ETF as a Commodity, Sidestepping Security Status Debate

XRP News Today: SEC Grants Approval for XRP ETF as a Commodity, Sidestepping Security Status Debate

Bitget-RWA2025/11/19 11:32
By:Bitget-RWA

- SEC approves Franklin Templeton's XRP ETF (ticker EZRP), marking XRP's institutional legitimacy as a commodity asset. - The ETF, holding XRP via Coinbase Custody, avoids airdrops/forks and sidesteps SEC's security classification dispute over XRP. - Market sees it as a catalyst for institutional crypto adoption, with potential inflows mirroring Bitcoin/ETH ETF success. - XRP's 11% post-approval price drop and regulatory uncertainty highlight risks despite 0.19% competitive fee structure.

The U.S. Securities and Exchange Commission (SEC) has made a notable move toward recognizing

as a legitimate institutional investment by , according to sources including Kenny Nguyen and documents from Franklin Templeton. This action represents a major milestone for XRP, currently the fourth-largest digital asset by market value, as it via conventional brokerage platforms. The ETF, named the Franklin XRP Trust, will be managed by Franklin Templeton, which oversees $1.6 trillion in assets, and is under the ticker EZRP.

Momentum for approval increased after Franklin Templeton

with the SEC, eliminating a delaying provision (Section 8(a)) that could have prolonged the review. This adjustment means the ETF could become active within 20 days unless the SEC objects. The fund’s design, which , does not distribute airdrops or forks to investors, streamlining compliance and reducing operational hurdles. Coinbase Custody will in offline storage, while will serve as the main broker for executing trades.

XRP News Today: SEC Grants Approval for XRP ETF as a Commodity, Sidestepping Security Status Debate image 0

Industry observers see the ETF as a driving force for greater institutional involvement. By allowing investors to gain exposure to XRP without direct ownership, the fund

that have traditionally kept mainstream investors away from digital assets. Experts anticipate that inflows could rival those seen by and ETFs, which have . Early demand is apparent: Canary Capital’s XRPC ETF, which debuted on Nasdaq, on its opening day. Nevertheless, XRP’s value has , a drop attributed to large holders selling and overall market weakness.

The ETF’s regulatory structure follows commodity-based standards, treating XRP in a manner similar to gold or oil under BZX Rule 14.11(e)(4). This approach differs from the SEC’s ongoing lawsuit against Ripple Labs, which claims XRP should be classified as a security.

by emphasizing XRP’s use in international payments and its increasing acceptance among institutions.

Despite the positive outlook, certain risks persist. The SEC has yet to issue a formal final approval, and regulatory review could still postpone the launch. Moreover, XRP’s price swings and cybersecurity issues highlight the importance of caution.

, which will be initially waived, making the ETF competitive with similar offerings.

Investors should keep an eye on SEC updates and exchange notifications for confirmation of the ETF’s activation. If trading commences as planned on November 18, the product could reshape XRP’s position in traditional finance, connecting the crypto world with institutional investors. For now, this milestone is still “anticipated,” but it highlights the growing trend of regulatory transparency and the integration of digital assets into mainstream finance.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Bitcoin Updates: ETF Withdrawals and Rising Short Positions Push Bitcoin Below Bearish Threshold

- Bitcoin fell below the 0.75 cost basis quantile, a key bear-market threshold identified by Glassnode, signaling renewed downward pressure. - ETF outflows surged $866.7M on November 13, with BlackRock's IBIT and Grayscale's Bitcoin Mini Trust leading redemptions amid $100,000 price drop. - Harvard's $443M IBIT investment contrasts with bearish technical signals like the "death cross," while Nansen tracks $5.7M in new short positions. - Tight futures liquidity and 46% Fed rate-cut probability amplify downs

Bitget-RWA2025/11/19 12:46

Bitcoin Updates Today: Is Crypto's Death Cross Indicating a Recovery or Warning of a Downturn?

- Cryptocurrency markets face selloff as Bitcoin , Ethereum , and XRP decline amid a "death cross" signal and waning institutional demand. - Technical analysis highlights Bitcoin's 50-day moving average nearing the 200-day line, historically linked to prolonged downturns or potential rebounds. - Blockchain data reveals $953M BTC moved from Mt. Gox wallets, triggering $1B in forced liquidations despite analysts labeling the transfers administrative. - Historical death crosses have preceded market bottoms, b

Bitget-RWA2025/11/19 12:46
Bitcoin Updates Today: Is Crypto's Death Cross Indicating a Recovery or Warning of a Downturn?

Aster News Today: DeFi Competition Heats Up: Incentivizing Liquidations to Draw in Traders

- Aster, a decentralized crypto exchange, launched "Machi mode" to reward traders with points for liquidations, embracing risk-taking culture. - Competitor Hyperliquid slashed taker fees by 90% via HIP-3 "growth mode," targeting liquidity providers and challenging centralized exchanges. - Both strategies reflect DeFi's arms race to attract traders through gamification (Aster) and technical efficiency (Hyperliquid), blurring financial utility with community identity. - Traders praised Aster's "failure-as-fe

Bitget-RWA2025/11/19 12:28
Aster News Today: DeFi Competition Heats Up: Incentivizing Liquidations to Draw in Traders

Olema’s Proposal Dampens Hopes for Trial, Sparks Decline Due to Dilution Concerns

- Olema Pharmaceuticals (OLMA) shares fell 6.9-7.2% post-announcement of a stock and warrant offering, triggering dilution concerns among investors. - The TD Cowen-led offering includes a 30-day greenshoe option for up to 15% additional shares, with proceeds intended to fund breast cancer therapies like palazestrant (Phase 3) and OP-3136 (Phase 1). - Despite recent 81% stock gains and positive SERD trial data from Roche, the offering overshadowed optimism, though analysts at H.C. Wainwright and Guggenheim

Bitget-RWA2025/11/19 12:28
Olema’s Proposal Dampens Hopes for Trial, Sparks Decline Due to Dilution Concerns